Selective Alleviation of Compulsive Lever-Pressing in Rats by D1, but not D2, Blockade: Possible Implications for the Involvement of D1 Receptors in Obsessive–Compulsive Disorder

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Neuropsychopharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1038/sj.npp.1300010PMID 12496943
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of extinction, pimozide, SCH 23390, and metoclopramide on food-rewarded operant responding of rats

  2004influential reference
• D-Amphetamine in obsessive-compulsive disorder

  2004influential reference
• Epidemiological and clinical

  2001influential reference
• Excessive lever pressing following post-training signal attenuation in rats: a possible animal model of obsessive compulsive disorder?

  2001cited by this paper
• Enhancement of excessive lever-pressing after post-training signal attenuation in rats by repeated administration of the D1 antagonist SCH 23390 or the D2 agonist quinpirole, but not the D1 agonist SKF 38393 or the D2 antagonist haloperidol.

  2001cited by this paper
• Neurobiology of the obsessive-compulsive spectrum disorders.

  2000cited by this paper
• The two revolutions

  2000cited by this paper
• Behavioral effects of cocaine on a transgenic mouse model of cortical-limbic compulsion.

  1999cited by this paper
• Psychopharmacology of conditioned reward: evidence for a rewarding signal at D1-like dopamine receptors

  1999cited by this paper
• Differential response of cortical-limbic neuropotentiated compulsive mice to dopamine D1 and D2 receptor antagonists.

  1999cited by this paper
• OCD-Like Behaviors Caused by a Neuropotentiating Transgene Targeted to Cortical and Limbic D1+ Neurons

  1999cited by this paper
• Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD).

  1998cited by this paper
• Dopamine D1-like receptors and reward-related incentive learning.

  1998cited by this paper
• Haloperidol, raclopride, and eticlopride induce microcatalepsy during operant performance in rats, but clozapine and SCH 23390 do not

  1998influential reference
• Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder

  1998cited by this paper
• Predictive reward signal of dopamine neurons.

  1998cited by this paper
• Epidemiology of obsessive-compulsive disorder: a world view.

  1997cited by this paper
• Update on pharmacologic management of OCD: agents and augmentation.

  1997cited by this paper
• Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder.

  1996cited by this paper
• Behavior-Relevant Changes in Nucleus Accumbens Dopamine Transmission Elicited by Food Reinforcement: An Electrochemical Study in Rat

  1996cited by this paper
• New developments in obsessive‐compulsive disorder research: implications for clinical management

  1996cited by this paper
• Different behavioral effects of haloperidol, clozapine and thioridazine in a concurrent lever pressing and feeding procedure

  1996influential reference
• The pathogenesis and treatment of obsessive-compulsive disorder.

  1996cited by this paper
• Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder.

  1995cited by this paper
• Pharmacological characterization of performance on a concurrent lever pressing/feeding choice procedure: effects of dopamine antagonist, cholinomimetic, sedative and stimulant drugs

  1994influential reference
• Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics.

  1994cited by this paper
• Electrochemical monitoring of extracellular dopamine in nucleus accumbens of rats lever-pressing for food.

  1994cited by this paper
• Chronic antagonist treatment does not alter the mode of interaction of dopamine with rat striatal dopamine receptors.

  1993cited by this paper
• The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesis.

  1993cited by this paper
• Chronic treatment with SCH 23390 increases the production rate of dopamine D1 receptors in the nigro-striatal system of the rat.

  1993cited by this paper
• The epidemiology and clinical features of obsessive compulsive disorder.

  1992cited by this paper
• Regulation of dopamine D1 receptors by chronic administration of structurally different D1 receptor antagonists: a quantitative autoradiographic study.

  1992cited by this paper
• Normal and abnormal information processing. A neuropsychological perspective on obsessive compulsive disorder.

  1992influential reference
• Current Concepts in the Pharmacological Treatment of Obsessive-Compulsive Disorder

  1992cited by this paper
• Obsessions and compulsions associated with cocaine abuse.

  1991influential reference
• Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder.

  1990cited by this paper
• Amphetamine psychosis.

  1990influential reference
• Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder?

  1990cited by this paper
• Historical Considerations

  1990influential reference
• Pathophysiology of obsessive-compulsive disorder.

  1989influential reference
• Animal models of compulsive behavior.

  1989cited by this paper
• The biology of obsessions and compulsions.

  1989cited by this paper
• Chronic treatment with dopamine receptor antagonists: behavioral and pharmacologic effects on D1 and D2 dopamine receptors

  1988cited by this paper
• Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology

  1987cited by this paper
• Repeated administration of (-)sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions.

  1987cited by this paper
• Obsessive-compulsive symptomatology in children with Tourette's syndrome.

  1987cited by this paper
• Clinical comparison of Tourette's disorder and obsessive-compulsive disorder.

  1987cited by this paper
• Obsessions and compulsions in Gilles de la Tourette's syndrome

  1986cited by this paper
• The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors.

  1986cited by this paper
• Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.

  1986cited by this paper
• Obsessive-compulsive symptoms following stimulants.

  1985cited by this paper
• Obsessional experience and compulsive behaviour : a cognitive-structural approach

  1985cited by this paper
• Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390.

  1985influential reference
• [3H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptors.

  1985cited by this paper
• Précis of The neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal system

  1982influential reference
• Obsessional Personality Disorder and Remembering

  1977influential reference
• Changes in Individual and Social Behavior Induced by Amphetamine and Related Compounds in Monkeys and Man

  1977cited by this paper
• The psychology of animal learning

  1974cited by this paper
• Amphetamine psychosis : description of the individuals and processes

  1967influential reference
• AMPHETAMINE PSYCHOSIS: I. DESCRIPTION OF THE INDIVIDUALS AND PROCESS

  1967influential reference
• Psychopathology of Forced Movements and the Oculogyric Crises of Lethargic Encephalitis.

  1933cited by this paper
• Psychopathology of Forced Movements in Oculogyric Crises

  1932cited by this paper

• Computational insights on asymmetrical \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$D_{1}$$\end{document}D1 and \do

  2023cites this paper
• Assessment of Repetitive and Compulsive Behaviors Induced by Pramipexole in Rats: Effect of Alpha-Synuclein-Induced Nigrostriatal Degeneration

  2022cites this paper
• Animal models of Obsessive-Compulsive Disorder (OCD)

  2022cites this paper
• Feed tossing behaviour of Holstein cows: evaluation of physiological stress state and rumen fermentation function

  2022cites this paper
• Stereotypies in the Autism Spectrum Disorder: Can We Rely on an Ethological Model?

  2021cites this paper
• The Psychopharmacology of Obsessive-Compulsive Disorder: A Preclinical Roadmap

  2020cites this paper
• Effects of linalool on extinction of mouse operant behaviour

  2020cites this paper
• Mesolimbic dopamine projections mediate cue-motivated reward seeking but not reward retrieval in rats

  2019cites this paper
• The Role of Serotonin and Dopamine Neurotransmitters in Obsessive-Compulsive Disorder

  2019cites this paper
• Naturalistic operant responses in deer mice (Peromyscus maniculatus bairdii) and its response to outcome manipulation and serotonergic intervention

  2019cites this paper
• Animal Models of Gambling-Related Behaviour

  2019cites this paper
• The measurements and mechanisms of restricted and repetitive behaviors in autism spectrum disorders

  2018cites this paper
• Ventral tegmental dopamine inputs to the nucleus accumbens mediates cue-triggered motivation but not reward expectancy

  2018cites this paper
• Ventral tegmental dopamine inputs to the nucleus accumbens mediates cue-triggered motivation but not reward expectancy

  2018cites this paper
• Chemogenetic inhibition of ventral tegmental area dopamine neurons or their inputs to the nucleus accumbens disrupts cue-triggered reward seeking but not reward taking

  2018cites this paper
• The Effect of Atorvastatin on Obsessive-compulsive Symptoms of Refractory Obsessive-compulsive Disorder (Add-on Therapy)

  2018cites this paper
• Chronic pramipexole treatment induces compulsive behavior in rats with 6‐OHDA lesions of the substantia nigra and ventral tegmental area

  2017influential citation
• Striatopallidal dysfunction underlies repetitive behavior in Shank3-deficient model of autism

  2017cites this paper
• Effect of Religious Cognitive Behavioral Therapy on Religious Obsessive-compulsive Disorder (3 and 6 months Follow-up)

  2017cites this paper
• Compulsivity in obsessive-compulsive disorder and addictions.

  2016cites this paper
• The Role of Serotonin in Orbitofrontal Function and Obsessive-Compulsive Disorder

  2015cites this paper
• Animal models of obsessive–compulsive disorder: utility and limitations of obsessions and compulsions in basal ganglia-related

  2015cites this paper
• Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder

  2015cites this paper
• From Thought to Action: How the Interplay Between Neuroscience and Phenomenology Changed Our Understanding of Obsessive-Compulsive Disorder

  2015cites this paper
• Animal models of obsessive–compulsive disorder: utility and limitations

  2015cites this paper
• The role of the cholinergic system in the signal attenuation rat model of obsessive-compulsive disorder.

  2013cites this paper
• The role of the cholinergic system in the signal attenuation rat model of obsessive-compulsive disorder

  2013cites this paper
• Dopaminergic control of cognitive flexibility in humans and animals

  2013cites this paper
• Evaluation of animal models of obsessive-compulsive disorder: correlation with phasic dopamine neuron activity.

  2013cites this paper
• General understanding , n euro-endocrinologic and ( epi ) genetic factors of stereotypy

  2013cites this paper
• Comparison of the MK-801-induced increase in non-rewarded appetitive responding with dopamine agonists and locomotor activity in rats

  2013cites this paper
• Current animal models of obsessive compulsive disorder: an update.

  2012influential citation
• Behavioral, Pharmacological, and Immunological Abnormalities after Streptococcal Exposure: A Novel Rat Model of Sydenham Chorea and Related Neuropsychiatric Disorders

  2012cites this paper
• Facilitation of extinction of operant behaviour in C57Bl/6 mice by chlordiazepoxide and d-cycloserine

  2012cites this paper
• Animal models of obsessive-compulsive disorder: exploring pharmacology and neural substrates.

  2012cites this paper
• Serotonin and Beyond: A Neurotransmitter Perspective of OCD

  2012cites this paper
• Outlining new frontiers for the comprehension of obsessive-compulsive disorder: a review of its relationship with fear and anxiety.

  2012cites this paper
• Cortico-striatal oxidative status, dopamine turnover and relation with stereotypy in the deer mouse.

  2011cites this paper
• Genetics of Childhood and Adolescent Anxiety

  2011cites this paper
• Dopamine, But Not Serotonin, Regulates Reversal Learning in the Marmoset Caudate Nucleus

  2011cites this paper
• Towards a comprehensive model of stereotypy: integrating operant and neurobiological interpretations.

  2011cites this paper
• Animal models of obsessive compulsive disorder: recent findings and future directions

  2011cites this paper
• The Role of Serotonin on Attentional Processes and Executive Functioning: Focus on 5-HT2C Receptors

  2011cites this paper
• The neurobiology of repetitive behavior: of mice….

  2011cites this paper
• High but not low frequency stimulation of both the globus pallidus and the entopeduncular nucleus reduces 'compulsive' lever-pressing in rats.

  2011cites this paper
• Unraveling the interactions between serotonin and dopamine in the compulsive and impulsive behaviour underlying obsessive-compulsive disorder

  2010cites this paper
• The Role of the Striatum in Compulsive Behavior in Intact and Orbitofrontal-Cortex-Lesioned Rats: Possible Involvement of the Serotonergic System

  2010cites this paper
• The role of NMDA receptors in the signal attenuation rat model of obsessive–compulsive disorder

  2010cites this paper
• N‐methyl d‐aspartate receptors are involved in the induction, but not expression stage of amphetamine sensitization in schedule‐induced polydipsia in rats

  2010cites this paper
• Role of dopaminergic DAD1 and DAD2 receptors in the sensitization of amphetamine-suppressed schedule-induced polydipsia in rats.

  2009cites this paper
• Ovarian hormones modulate 'compulsive' lever-pressing in female rats.

  2009influential citation
• Dopamine in the prefrontal cortex regulates rats behavioral flexibility to changing reward value.

  2009cites this paper
• Brief report Dopamine D 1 receptor binding in the striatum of patients with obsessive-compulsive disorder

  2009cites this paper
• Hormones and Behavior

  2009cites this paper
• Obsessive-compulsive disorder and related disorders: a comprehensive survey

  2009cites this paper
• High frequency stimulation and pharmacological inactivation of the subthalamic nucleus reduces 'compulsive' lever-pressing in rats.

  2009cites this paper
• Dopamine D1 receptor binding in the striatum of patients with obsessive-compulsive disorder.

  2009cites this paper
• Experimental therapeutics for refractory obsessive-compulsive disorder: translational approaches and new somatic developments.

  2008cites this paper
• The role of the subthalamic nucleus in ‘compulsive’ behavior in rats

  2008cites this paper
• Animal Models of Obsessive–Compulsive Disorder: From Bench to Bedside via Endophenotypes and Biomarkers

  2008cites this paper
• Dopaminergic and serotonergic modulation of persistent behaviour in the reinforced spatial alternation model of obsessive–compulsive disorder

  2008cites this paper
• Facilitation of extinction of operant behaviour in mice by d-cycloserine

  2008cites this paper
• Strain differences in 'compulsive' lever-pressing.

  2007cites this paper
• Effects of chlordiazepoxide on extinction of operant behaviour in mice vary with time of administration and rate of extinction

  2007cites this paper
• Neurobiology of Obsessive-Compulsive Disorder: Serotonin and Beyond

  2007cites this paper
• Animal models of exposure therapy: A selective review

  2007cites this paper
• [Influence of blockade of the dopaminergic D1/D2 receptors on choice behaviour at different by validity reinforcements in cats].

  2006cites this paper
• The effects of early life trauma on the neurochemistry and behaviour of the adult rat

  2006cites this paper
• [Haloperidol does not alter a choice strategy for reinforcement value in cats].

  2006cites this paper
• Obsessive-compulsive disorder

  2006cites this paper
• Maternal age at the birth of the first child as an epistatic factor in polygenic disorders

  2006cites this paper
• Current animal models of obsessive compulsive disorder: a critical review.

  2006influential citation
• The signal attenuation rat model of obsessive–compulsive disorder: a review

  2006influential citation
• Psychostimulant-Induced Behavior as an Animal Model of Obsessive-Compulsive Disorder: An Ethological Approach to the Form of Compulsive Rituals

  2005cites this paper
• Role of the orbital cortex and of the serotonergic system in a rat model of obsessive compulsive disorder.

  2005cites this paper
• ‘Compulsive’ lever pressing in rats is enhanced following lesions to the orbital cortex, but not to the basolateral nucleus of the amygdala or to the dorsal medial prefrontal cortex

  2005cites this paper
• The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence.

  2004cites this paper
• ‘Compulsive’ lever-pressing in rats is attenuated by the serotonin re-uptake inhibitors paroxetine and fluvoxamine but not by the tricyclic antidepressant desipramine or the anxiolytic diazepam

  2004cites this paper
• A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors.

  2004cites this paper
• Current and potential pharmacological treatments for obsessive-compulsive disorder

  2003cites this paper
• Animal models of anxiety disorders

  2003cites this paper